Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Davis currently holds 186,555 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Davis has been a net seller of HRTX stock. They have purchased $0 and sold $33.4M worth of shares.
Stephen Davis's most recent insider trade was on Aug 19, 2024, when they sold 31,747 shares at $15.28 per share.
Stephen Davis serves as Executive at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have executed 114 insider transactions totaling $33.4M over their tenure at the company.
Stephen Davis holds the position of Executive at HERON THERAPEUTICS, INC. /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Stephen Davis has shown a selling trading pattern, with $0 in total purchases and $33.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Davis was on Jul 14, 2023, when they sold $3.0M worth of ACAD shares. This transaction involved 100,000 shares at $30.04 per share.
Stephen Davis currently owns 186,555 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Davis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Davis has 114 Form 4 filings on record as an insider at HERON THERAPEUTICS, INC. /DE/.
Set alerts for Stephen Davis and 40,000+ other insiders.